Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BG.5NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
BA.2.61NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
BA.5.1.23NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
BA.2.74NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
BM.3NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
BA.5.8NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
BA.2.13.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
BA.5.1.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
BE.1.1.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
XAZNNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
BA.5.1.16NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
B.1.165NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
B.1.444NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
AY.29.2 (Delta)NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
BC.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
BA.2.3.13NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
BA.2.56NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
BA.2.10NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
B.1.1.424NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
AY.79 (Delta)NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
BA.2.33NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
B.1.160.27NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
B.1.177.68NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
XBB.1.5.42NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
GW.4NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
HY.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
FL.20.2NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
JN.1.30NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
JN.1.1.9NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
GJ.1.2.4NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
DV.7.1.2NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
JR.1.1.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
XDENNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
GK.2NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
HN.6NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
JY.1.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
P.7NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
EG.2.1ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-4251.49China
MB.1ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-4251.49China
EG.10.1.1ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-4251.49China
GJ.1.2.4ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-4251.49China
GK.1.10ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-4251.49China
BF.5ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-4251.49China
BA.2.58ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-4251.49China
A.27ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-4251.49China
CP.8ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-4260.71Germany
BA.5.2.25NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-4270.22Thailand
CP.8NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-4270.22Thailand
BA.5.2.18NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-4270.22Thailand
CR.1.1NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-4270.22Thailand
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used